Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

A bull got very sick and had to be put down after eating hairy vetch for months.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Dermatological conditions are complex and treatments often have mixed results.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

COVID-19 can cause significant hair loss.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.